Chemotherapy of Rodent Malaria.
Annual rept. 16 Oct 88-15 Oct 89,
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE (UNITED KINGDOM)
Pagination or Media Count:
Data from in vivo blood schizontocidal activity tests rodent malaria with WR 149244, WR 256473, WR 93133, WR 242511, WR 238605 and Loratadine are presented. The final results from the continuing study on cross-resistance and first data from a series of experiments examining the influence of a range of WRAIR compounds, as well as some antihistaminic drugs, in combination with chloroquine, mefloquine, halofantrine or artemisinin on resistance to these primary antimalarials in appropriate strains of Plasmodium yoelii are also included. Studies on gametocytocidal activity of four metabolites of primaquine and four Cinchona alkaloids are described. Two floxacrine analogs WR 243251 and WR 250547, and two 8-aminoquinolines WR 199508 and WR 238605, a tetrahydrofuran WR 93133, and two antibiotics spiramycin and lincomycin are examined for causal prophylactic activity against P.y.nigeriensis.